Following the reports indicating that exogenous NRG1 improves metabolic outcomes implicated with obesity [47, 57–60], we tested whether exogenous NRG1 administration prevents/delays the onset of obesity symptoms. The gene discussed is NRG1; the disease is obesity due to melanocortin 4 receptor deficiency.